TYSON 2.0, the premium cannabis brand of legendary boxer, entrepreneur and advocate Mike Tyson and Carma HoldCo Inc. are teaming up with the multinational pharmaceutical company PHCANN to exclusively cultivate, manufacture and distribute TYSON 2.0 branded THC products across Germany and the UK, Benzinga has exclusively learned. PHCANN is a multinational pharmaceutical company with headquarters in Amsterdam and a representative office in Germany.

“Collaborating with PHCANN to bring my premium TYSON 2.0 cannabis products to Germany and the UK is a natural move as industry heavyweights,” said TYSON 2.0 co-founder and chief brand officer Mike Tyson. “I’m excited to make our world-class products available to medical cannabis patients in the region. Together, we’re setting new standards and delivering something that no one else is bringing to the table.”

PHCANN International co-founder Yuval Soiref said the company chose to partner with Carma HoldCo for “their excellence in leveraging cultural influence to redefine industries. TYSON 2.0’s extensive selection of acclaimed cannabis products, will be available to German and UK patients this summer – on track to make it one of the largest cannabis brands in the world.”

The announcement comes ahead of the Benzinga Cannabis Capital Conference in Florida on April 16-17, where Mike Tyson and his sidekick Ric Flair will be speaking on a panel. The International Cannabis Business Conference (ICBC) is also taking place on April 16-17 in Berlin, which PHCANN International representatives will attend.

Pivotal Moment

PHCANN International CEO Sasho Stefanoski called the partnership part of a pivotal moment in the progress of the cannabis industry in Europe. “We embrace this opportunity as many countries look toward regulatory changes. To partner with the TYSON 2.0 brand and join forces as well-respected industry leaders puts us in a position where we can lead the charge in pushing industry boundaries.”

Carma HoldCo CEO Adam Wilks added that the venture marks a significant milestone in Tyson 2.0’s mission to expand its global presence and provide quality products to consumers worldwide.

“With the TYSON 2.0 brand, we are excited to partner with PHCANN because of its track record of pushing the boundaries in European and other international markets and operating at a level above the current standard,” Wilks said. “By joining forces, we can deliver transformative experiences to medical cannabis consumers in Germany and the UK while leveraging our cultural influence to make a meaningful impact on the market.”

The inclusion of such high-profile personalities in the Benzinga Cannabis Capital Conference underscores the evolving dynamics of the cannabis industry, where the lines between celebrity influence and entrepreneurial venture blur. Tyson and Flair’s panel will provide unique insights into the importance of strategic partnerships and cultural adaptation as well as offer attendees a rare glimpse into the regulatory challenges and opportunities awaiting cannabis brands aiming to expand internationally. Get your tickets now on bzcannabis.com